The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies

References

• Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365–1376. doi:10.1016/S0140-6736(06)69561-5
   PubMed Web of Science ®Google Scholar
• Sadzot-Delvaux C, Rentier B, Wutzler P, et al. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis. 2008;197(2):185–190. doi:10.1086/522163
   Web of Science ®Google Scholar
• Bardach A, Cafferata ML, Klein K, Cormick G, Gibbons L, Ruvinsky S. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean–a systematic review and meta-analysis. Pediatr Infect Dis J. 2012;31(12):1263–1268. doi:10.1097/INF.0b013e31826ff3a5
   PubMed Web of Science ®Google Scholar
• Czumbel I, Quinten C, Lopalco P, et al. Management and control of communicable diseases in schools and other child care settings: systematic review on the incubation period and period of infectiousness. BMC Infect Dis. 2018;18(1):199. doi:10.1186/s12879-018-3095-8
   PubMed Web of Science ®Google Scholar
• Gnann J. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis. 2002;186(1):S91–S98.
   Web of Science ®Google Scholar
• Dunkle LM, Arvin AM, Whitley RJ, et al. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med. 1991;325(22):1539–1544. doi:10.1056/NEJM199111283252203
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Guidance for Varicella Vaccination in the European Union; 2015.
   Google Scholar
• Marchetti M, Kühnel UM, Colombo GL, Esposito S, Principi N. Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age. Hum Vaccin. 2007;3(1):14–22. doi:10.4161/hv.3.1.3657
   PubMed Web of Science ®Google Scholar
• Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis. 1995;172(3):706–712. doi:10.1093/infdis/172.3.706
   PubMed Web of Science ®Google Scholar
• Krugman S, Goodrich CH, Ward R. Primary varicella pneumonia. N Engl J Med. 1957;257(18):843–848. doi:10.1056/NEJM195710312571801
   Web of Science ®Google Scholar
• Gogos CA, Bassaris HP, Vagenakis AG. Varicella pneumonia in adults. A review of pulmonary manifestations, risk factors and treatment. Respiration. 1992;59(6):339–343. doi:10.1159/000196084
   Web of Science ®Google Scholar
• Preblud SR. Varicella: complications and costs. Pediatrics. 1986;78:4.
   Web of Science ®Google Scholar
• Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J. 2002;21(10):931–934. doi:10.1097/00006454-200210000-00009
   PubMed Web of Science ®Google Scholar
• Fangjun Z, Harpaz R, Jumaan A, et al. Impact of Varicella Vaccination on Health Care Utilization. JAMA. 2005;294(5):7.
   Google Scholar
• Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) Robert Koch-Institut. Epidemiol Bull. 2003;2003.
   Google Scholar
• Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics. 2004;114(3). doi:10.1542/peds.2004-0012
   Web of Science ®Google Scholar
• Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352(5):450–458. doi:10.1056/NEJMoa042271
   PubMed Web of Science ®Google Scholar
• Lopez A, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000–2006: the 1-dose varicella vaccination era. Pediatrics. 2011;127(2):2. doi:10.1542/peds.2010-0962
   Web of Science ®Google Scholar
• Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128(2):214–220. doi:10.1542/peds.2010-3385
   PubMed Web of Science ®Google Scholar
• Lieu TA, Cochi SL, Black SB. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA. 1994;271(5):375–381. doi:10.1001/jama.1994.03510290057037
   PubMed Web of Science ®Google Scholar
• Kwong JC, Tanuseputro P, Zagorski B, et al. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program? Vaccine. 2008;26(47):6006–6012. doi:10.1016/j.vaccine.2008.08.016
   PubMed Web of Science ®Google Scholar
• Amodio E, Tramuto F, Cracchiolo M, et al. The impact of ten years of infant universal varicella vaccination in Sicily, Italy (2003-2012). Hum Vaccin Immunother. 2015;11(1):236–239. doi:10.4161/hv.36157
   PubMed Web of Science ®Google Scholar
• Pezzotti P, Bellino S, Prestinaci F, et al. The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900–2015. Vaccine. 2018;36(11):1435–1443. doi:10.1016/j.vaccine.2018.01.065
   PubMed Web of Science ®Google Scholar
• Ministro della Salute. Le novità del decreto legge sui vaccini. 2017.
   Google Scholar
• World Health Organization. Principles and Considerations for Adding a Vaccine to a National Immunization Programme from Decision to Implementation and Monitoring; 2014.
   Google Scholar
• Wolfson LJ, Daniels VJ, Pillsbury M, et al. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model. PLoS One. 2019;14(8):e0220921. doi:10.1371/journal.pone.0220921
   PubMed Web of Science ®Google Scholar
• Castillo-Chavez C, Hethcote HW, Andreasen V, Levin SA, Liu WM. Epidemiological models with age structure, proportionate mixing, and cross-immunity. J Math Biol. 1989;27(3):233–258. doi:10.1007/BF00275810
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO vaccine-preventable diseases: monitoring system 2018. Available from: http://apps.who.int/immunization_monitoring/globalsummary/countries?Countrycriteria%5Bcountry%5D%5B%5D=ITA. Accessed March 18, 2020.
   Google Scholar
• Department of Economic and Social Affairs. Population Prospects: The 2017 Revision. United Nations: Population Division; 2017.
   Google Scholar
• Fumanelli L, Ajelli M, Manfredi P, Vespignani A, Merler S. Inferring the structure of social contacts from demographic data in the analysis of infectious diseases spread. PLoS Comput Biol. 2012;8(9):e1002673. doi:10.1371/journal.pcbi.1002673
   PubMed Web of Science ®Google Scholar
• Agenzia Nazionale per i Servizi Sanitari Regionali. Tariffario Prestazioni Sanitarie Specialistiche Ambulatoriali - Visita Generale Agenzia Nazionale per i Servizi Sanitari Regionali; 2014.
   Google Scholar
• Azzari C, Massai C, Poggiolesi C, et al. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses. Curr Med Res Opin. 2007;12:2945–2954. doi:10.1185/030079907X242610
   Web of Science ®Google Scholar
• Trucchi C, Gabutti G, Rota MC, Bella A. Burden of varicella in Italy, 2001–2010: analysis of data from multiple sources and assessment of universal vaccination impact in three pilot regions. J Microbiol. 2015;64(11):1387–1394.
   Google Scholar
• Morandi DI. Prestazioni specialistiche ambulatoriali Confronto tra le tariffe nazionale. Agenzia Nazionale per i Servizi Sanitari Regionali; 2014.
   Google Scholar
• Boccalini S, Bonanni P, Bechini A. Preparing to introduce the varicella vaccine into the Italian immunisation programme: varicella-related hospitalisations in Tuscany, 2004-2012. Euro Surveill. 2016;21(24). doi:10.2807/1560-7917.ES.2016.21.24.30257
   Google Scholar
• Ministero dell’Economia e delle Finanze. Libro verde della spesa pubblica 2007 - aggiornato con l’indice dei prezzi al consumo Ministero dell’Economia e delle Finanze. 2007.
   Google Scholar
• Agenzia Nazionale per i Servizi Sanitari Regionali. Tariffario Prestazioni Sanitarie Specialistiche Ambulatoriali - Radiografia del torace di routine Agenzia Nazionale per i Servizi Sanitari Regionali. 2014.
   Google Scholar
• Coudeville L, Brunot A, Giaquinto C, Lucioni C, Dervaux B. Varicella vaccination in Italy - an economic evaluation of different scenarios. PharmacoEconomics. 2004;22(13):839–855. doi:10.2165/00019053-200422130-00003
   PubMed Web of Science ®Google Scholar
• EuroStat. Retribuzioni e costo del lavoro. 2018.
   Google Scholar
• Farmadati online database, Available from: https://www.farmadati.it/. Accessed in 2008
   Google Scholar
• National Law N. 386/1974, included in the National Official Bulletin “GU Serie Generale n.225 del 29-08-1974”, art. N. 9, Link: https://www.gazzettaufficiale.it/eli/id/1974/08/29/074U0386/sg
   Google Scholar
• Schink T, Holstiege J, Kowalzik F, Zepp F, Garbe E. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination. Vaccine. 2014;32(6):645–650. doi:10.1016/j.vaccine.2013.12.011
   PubMed Web of Science ®Google Scholar
• Ma S-J, Xiong Y-Q, Jiang L-N, Chen Q. Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: a systematic review and meta-analysis. Vaccine. 2015;33(31):3636–3649. doi:10.1016/j.vaccine.2015.06.009
   PubMed Web of Science ®Google Scholar
• Kowalzik F, Faber J, Knuf M. MMR and MMRV vaccines. Vaccine. 2018;36(36):5402–5407. doi:10.1016/j.vaccine.2017.07.051
   PubMed Web of Science ®Google Scholar
• Gabutti G, Kuhdari P, Ferioli S, Trucchi C. Hospital admissions for seizure in Italy: a decennial retrospective analysis with a special focus on the burden in the pediatric age. Neurol Sci. 2015;36(9):1667–1673. doi:10.1007/s10072-015-2230-1
   PubMed Web of Science ®Google Scholar
• Christensen H, Trotter CL. Modelling the cost-effectiveness of catch-up ‘MenB’ (Bexsero) vaccination in England. Vaccine. 2017;35(2):208–211. doi:10.1016/j.vaccine.2016.11.076
   PubMed Web of Science ®Google Scholar
• Supplemento Ordinario n.8 alla Gazzetta Ufficiale n.23 - Tariffe delle prestazioni di assistenza ospedaliera per acuti - Convulsioni e cefalea.  2012
   Google Scholar
• Kuter B, Matthews H, Shinefield H, et al. Ten Year Follow-up of Healthy Children Who Received One or Two Injections of Varicella Vaccine. Pediatr Res. 2004;23(2):132–137.
   Google Scholar
• Holl K, Sauboin C, Amodio E, Bonanni P, Gabutti G. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy. BMC Public Health. 2016;16(1):1103. doi:10.1186/s12889-016-3738-x
   PubMed Web of Science ®Google Scholar
• Ouwens MJNM, Littlewood KJ, Sauboin C, et al. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix. Clin Ther. 2017;37(4):816–829. doi:10.1016/j.clinthera.2014.12.017
   Web of Science ®Google Scholar
• Prymula R, Riise Bergsaker M, Esposito S, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014;383(9925):1313–1324. doi:10.1016/S0140-6736(12)61461-5
   PubMed Web of Science ®Google Scholar
• Sauboin C, Holl K, Bonanni P, et al. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting. BMC Infect Dis. 2019;19(1):126. doi:10.1186/s12879-019-3759-z
   PubMed Web of Science ®Google Scholar
• Povey M, Henry O, Riise Bergsaker MA, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a Phase 3 multicentre, observer-blind, randomised, controlled trial. Lancet Infect Dis. 2019;19(3):287–297. doi:10.1016/S1473-3099(18)30716-3
   PubMed Web of Science ®Google Scholar
• Quinn HE, Gidding HF, Marshall HS, et al. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program. J Infect. 2019;78(3):220–225. doi:10.1016/j.jinf.2018.11.009
   PubMed Web of Science ®Google Scholar
• Zhu S, Zeng F, Xia L, He H, Zhang J. Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: results from a meta-analysis. Am J Infect Control. 2018;46(1):e1–e7. doi:10.1016/j.ajic.2017.07.029
   PubMed Web of Science ®Google Scholar
• Yin M, Xu X, Liang Y, Ni J. Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination: a meta-analysis. Expert Rev Vaccines. 2018;17(4):351–362. doi:10.1080/14760584.2018.1433999
   PubMed Web of Science ®Google Scholar
• Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137(3):e20153741. doi:10.1542/peds.2015-3741
   PubMed Web of Science ®Google Scholar
• Cheng H, Chang L, Lu C, Huang L. Epidemiology of breakthrough varicella after the implementation of a universal varicella vaccination program in Taiwan, 2004–2014. Sci Rep. 2018;8(1):1. doi:10.1038/s41598-018-35451-y
   Web of Science ®Google Scholar
• Littlewood KJ, Ouwens MJ, Sauboin C, Tehard B, Alain S, Denis F. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster. Clin Ther. 2015;37(7):830–841. doi:10.1016/j.clinthera.2015.01.006
   Web of Science ®Google Scholar
• Attema AE, Brouwer W, Claxton K. Discounting in economic evaluations. PharmacoEconomics. 2018;36(7):745–758. doi:10.1007/s40273-018-0672-z
   PubMed Web of Science ®Google Scholar
• Gabutti G, Rota MC, De Donno A, et al. Sero-epidemiology of VZV infection in Italy: impact evaluation of extensive vaccination. Epidemiol Prev. 2014;38(6):57–61.
   Google Scholar
• World Health Organization. Weekly epidemiological record 2014
   Google Scholar
• World Health Organization. Guide for Standardization of Economic Evaluations of Immunization Programmes; 2008.
   Google Scholar
• Centers for Disease Control and Prevention. Direct and Indirect Effects of Routine Vaccination of Children with 7-Valent Pneumococcal Conjugate Vaccine on Incidence of Invasive Pneumococcal Disease–United States, 1998–2003; 2005.
   Google Scholar
• Drolet M, Bénard É, Boily M-C, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(5):565–580. doi:10.1016/S1473-3099(14)71073-4
   PubMed Web of Science ®Google Scholar
• Department of Economic and Social Affairs. Birth by Age of Mother - World Population Prospects: 2017 Revision. United Nations: Population Division; 2017.
   Google Scholar
• Hoang TV, Coletti P, Melegaro A, et al. A systematic review of social contact surveys to inform transmission models of close contact infections. BioRxiv. 2018.
   Google Scholar
• van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine. 2012;30(6):1225–1234. doi:10.1016/j.vaccine.2011.11.026
   PubMed Web of Science ®Google Scholar
• Spackova M, Wiese-Posselt M, Dehnert M, Matysiak-Klose D, Heininger U, Siedler A. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010;28(3):686–691. doi:10.1016/j.vaccine.2009.10.086
   PubMed Web of Science ®Google Scholar
• Giaquinto C, Gabutti G, Baldo V, et al. Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy. BMC Infect Dis. 2018;18(1):103. doi:10.1186/s12879-018-3017-9
   PubMed Web of Science ®Google Scholar